01 August 2005
NO(2)-induced acute and chronic lung injury cause imbalance of glutathionemetabolism in type II pneumocytes.Renate Hochscheid, Ute Schuchmann, Elke Kotte, Stephan Kranz, Sven Heinrichs, Bernd Muller
Med Sci Monit 2005; 11(8): BR273-279 :: ID: 200945
Background: During inspiration the lung is exposed to numerous oxidantsand therefore has developed a system of antioxidant defense. This organ, besides the liver, is the majorsource of glutathione (GSH) metabolism, from which type II pneumocytes are metabolically the most activecells. Material/Methods: To analyze oxidative stress, rats were exposed to air (control) or to 10 ppmnitrogen dioxide (NO(2)) for 3 and 20 days to induce acute and chronic lung injury. As measure of oxidativestress, GSH/GSSG ratios in blood, bronchoalveolar lavage (BAL) and type II pneumocytes were determined.Lipid peroxidation (LPO) was also measured in type II cells. To investigate the basis of these observations,GSH metabolism in type II pneumocytes was studied, analyzing mRNA expression of g-glutamylcystein synthetase(gamma-GCS), glutathione synthetase (GS), gamma-glutamyltranspeptidase (gamma-GT), glutathione peroxidases(GPXs) and glutathione reductase (GR). Furthermore, enzyme activities of GPX and GR were determined.Results: In acute and chronic lung injury the GSH/GSSG ratio was reduced in blood and BAL, but therewas no change in type II pneumocytes. LPO in type II cells was only reduced in acute lung injury. Inboth kinds of lung injury mRNA expression of gamma-GCS, GS and GPX3 decreased, while expression of gamma-GTand GR increased. GPX4 mRNA expression decreased in acute lung injury and increased in the chronic state.Enzyme activity of GPX and GR was generally increased in lung injury. Conclusions: In NO(2) induced acuteand chronic lung injury, GSH metabolism is imbalanced.
Keywords: Chronic Disease, Enzymes - genetics, Glutathione - biosynthesis, Glutathione - metabolism, Glutathione Peroxidase - metabolism, Lung - drug effects, Lung - injuries, Lung - metabolism, Lung - pathology, Nitrogen Dioxide - toxicity, Oxidation-Reduction - drug effects, Oxidative Stress - drug effects, RNA, Messenger - genetics, RNA, Messenger - metabolism, Chronic Disease, Enzymes - genetics, Glutathione - metabolism, Glutathione Peroxidase - metabolism, Lung - pathology, Lung Injury, Nitrogen Dioxide - toxicity, Oxidation-Reduction - drug effects, Oxidative Stress - drug effects, RNA, Messenger - metabolism
01 June 2023 : EditorialEditorial: Infectious Disease Surveillance Using Artificial Intelligence (AI) and its Role in Epidemic and Pandemic Preparedness
Med Sci Monit 2023; 29:e941209
08 Jun 2023 : Clinical ResearchRisk Factors for New Vertebral Compression Fracture After Percutaneous Vertebral Augmentation: A Retrospect...
Med Sci Monit In Press; DOI: 10.12659/MSM.940134
08 Jun 2023 : Clinical ResearchA Nomogram for Identifying HR+/Her2- Breast Cancer Patients with Positive Sentinel Lymph Nodes and Omitted ...
Med Sci Monit In Press; DOI: 10.12659/MSM.940124
08 Jun 2023 : Clinical ResearchBurden of COVID-19 on Mental Health of Resident Doctors in Poland
Med Sci Monit In Press; DOI: 10.12659/MSM.940208
08 Jun 2023 : Clinical ResearchRisk Prediction for Rapidly Progressive Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis: Th...
Med Sci Monit In Press; DOI: 10.12659/MSM.940251
Most Viewed Current Articles
13 Nov 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit 2021; 27:e932788
30 Dec 2021 : Clinical ResearchRetrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...
Med Sci Monit 2021; 27:e935379
08 Mar 2022 : Review articleA Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...
Med Sci Monit 2022; 28:e936292
01 Jan 2022 : EditorialEditorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...
Med Sci Monit 2022; 28:e935952